CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials
By K. F. Schulz, Douglas G. Altman, David Moher. Journal of Pharmacology and Pharmacotherapeutics, 2010
2,117 citations recorded by the source corpus.
The CONSORT statement is used worldwide to improve the reporting of randomised controlled trials. Kenneth Schulz and colleagues describe the latest version, CONSORT 2010, which updates the reporting guideline based on new methodological evidence and accumulating experience.To encourage dissemination of the CONSORT 2010 Statement, this article is freely accessible on bmj.com and will also be published in the Lancet, Obstetrics and Gynecology, PLoS Medicine, Annals of Internal Medicine, Open Medicine, Journal of Clinical Epidemiology, BMC Medicine, and Trials.
Subfields: Statistics and Probability, Surgery
View Paper: https://www.semanticscholar.org/paper/2ac3704dd8e74079aed3811acf87aedb31e08878
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Statistics and Probability
- David Moher
- Douglas G. Altman
- S. Richards
- John L Campbell
- A. Dickens
- C. Greaves
- Taixiang Wu
- H. MacPherson
In Surgery
Citations in the corpus
- Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement (2010, positive): “The group also suggested that the revised STRICTA statement, when published, should be presented as embedded within the two-group parallel trial CONSORT checklist [10] and its non-pharmacological treatment extension checklist [14].”
- Interventions targeting social isolation in older people: a systematic review (2011, positive): “Increased adherence to reporting guidelines such as CONSORT [92] for RCT studies and STROBE [93] for observational studies will also enhance the utility of intervention evaluations.”